✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Nutraceuticals Market Research Report Information By Type (Vitamins & Minerals, Probiotics, Proteins & Peptides, Omega Fatty Acids, and Others), By Source (Plant, Animal, and Microbial), By Form (Capsules, Tablets & Softgels, Powder, and Liquid & Gummies), By Distribution Channel (Store-Based and Non-Store-Based)


ID: MRFR/F-B & N/1620-CR | 100 Pages | Author: Sakshi Gupta| February 2021

Market Segmentation


Nutraceuticals Type Outlook (USD Million, 2018-2030)




  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others




Nutraceuticals Source Outlook (USD Million, 2018-2030)




  • Plant




  • Animal




  • Microbial




Nutraceuticals Form Outlook (USD Million, 2018-2030)




  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies




Nutraceuticals Distribution Channel Outlook (USD Million, 2018-2030)




  • Store-Based




  • Non-Store-Based




Nutraceuticals Regional Outlook (USD Million, 2018-2030)




  • North America Outlook (USD Million, 2018-2030)






  • North America Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • North America Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • North America Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • North America Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • US Outlook (USD Million, 2018-2030)







  • US Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • US Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • US Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • US Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • CANADA Outlook (USD Million, 2018-2030)







  • Canada Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Canada Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Canada Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Canada Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based






  • Europe Outlook (USD Million, 2018-2030)






  • Europe Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Europe Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Europe Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Europe Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • Germany Outlook (USD Million, 2018-2030)







  • Germany Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Germany Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Germany Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Germany Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • France Outlook (USD Million, 2018-2030)







  • France Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • France Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • France Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • France Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • UK Outlook (USD Million, 2018-2030)







  • UK Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • UK Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • UK Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • UK Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • ITALY Outlook (USD Million, 2018-2030)







  • ITALY Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • ITALY Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • ITALY Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • ITALY Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based






  • SPAIN Outlook (USD Million, 2018-2030)






  • SPAIN Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • SPAIN Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • SPAIN Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • SPAIN Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • Rest Of Europe Outlook (USD Million, 2018-2030)







  • Rest Of Europe Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Rest Of Europe Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Rest Of Europe Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Rest Of Europe Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based






  • Asia-Pacific Outlook (USD Million, 2018-2030)






  • Asia-Pacific Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Asia-Pacific Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Asia-Pacific Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Asia-Pacific Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • China Outlook (USD Million, 2018-2030)







  • China Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • China Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • China Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • China Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • Japan Outlook (USD Million, 2018-2030)







  • Japan Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Japan Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Japan Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Japan Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • India Outlook (USD Million, 2018-2030)







  • India Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • India Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • India Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • India Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • Australia Outlook (USD Million, 2018-2030)







  • Australia Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Australia Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Australia Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Australia Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • Rest of Asia-Pacific Outlook (USD Million, 2018-2030)







  • Rest of Asia-Pacific Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Rest of Asia-Pacific Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Rest of Asia-Pacific Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Rest of Asia-Pacific Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based






  • Rest of the World Outlook (USD Million, 2018-2030)






  • Rest of the World Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Rest of the World Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Rest of the World Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Rest of the World Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based






  •  







    • Middle East Outlook (USD Million, 2018-2030)







  • Middle East Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Middle East Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Middle East Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Middle East Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • Africa Outlook (USD Million, 2018-2030)







  • Africa Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Africa Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Africa Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Africa Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based







    • Latin America Outlook (USD Million, 2018-2030)







  • Latin America Nutraceuticals Type






  • Vitamins & Minerals




  • Probiotics




  • Proteins & Peptides




  • Omega Fatty Acids




  • Others






  • Latin America Nutraceuticals Source






  • Plant




  • Animal




  • Microbial






  • Latin America Nutraceuticals Form






  • Capsules




  • Tablets & Softgels




  • Powder




  • Liquid & Gummies






  • Latin America Nutraceuticals Distribution Channel






  • Store-Based




  • Non-Store-Based



Research Methodology on Nutraceuticals Market


Introduction


The nutraceuticals market is growing steadily and is expected to grow further in the coming years. It is estimated that the global nutraceuticals market will reach an all-time high revenue by 2030. The increase in demand for nutraceuticals is mainly driven by increasing awareness about the importance of regular nutritional supplement intake, as well as the growing demand for functional foods and beverages, among other factors.


What is a nutraceutical?


It is a combination of nutrition and pharmaceuticals and refers to a food or food product that provides medical benefits and health benefits that go beyond just providing nutrition, vitamins and minerals.


This research methodology explores the following research question, “What are the factors driving the growth of the nutraceuticals market?” to gain insights into the market dynamics of the nutraceuticals sector. The research methodology includes a review of existing secondary sources of information, such as market studies, and also involves interviews and surveys of relevant stakeholders to collect primary information.


Objectives



  • To provide an overview of the nutraceuticals market.

  • To study the growth drivers and trends in the nutraceuticals market.

  • To assess consumer behaviour and preferences when it comes to nutraceuticals.

  • To analyse industry experts’ views on the potentials and opportunities of the nutraceuticals market.


Literature Review


The literature review for this research report includes an extensive review of secondary sources such as market studies, reports and journals related to nutraceuticals. This enables the researcher to gain an understanding of the global nutraceuticals market and its dynamics. As part of the research, the researchers also conduct a review of industry experts opinions on the potential and opportunities of the nutraceuticals market.


Research Design


The researchers utilized a combination of qualitative and quantitative research designs to gain insights into the factors driving the growth of the nutraceuticals market. The research involves a combination of surveys, interviews and focus groups, as well as data collection and analysis.


Data Collection Method


The primary data for this research project is collected through interviews and surveys of relevant stakeholders. The interviewees include industry experts, nutraceuticals manufacturers, industry associations, distributors and retailers.


Analysis Method


The collected data is analysed using a combination of techniques such as trend analysis, content analysis, case study analysis and interpretative analysis and the results of the analysis are presented in a report.


Sampling


The sample for this research project includes a sample of 300 customers, 100 experts in the nutraceuticals industry, 20 nutraceuticals manufacturers, 20 industry associations, 20 distributors and 20 retailers.


Timeline


The research project is completed within 12 weeks, with the following timeline:



  • Week 1: Developing the research proposal and methodology

  • Week 2: Data collection (surveys, interviews, focus groups)

  • Week 3: Analyzing collected data

  • Week 4: Preparing the report

  • Week 5 – 9: Revising the report and presenting results

  • Week 10: Finalizing the report

  • Week 11: Print and present the report

  • Week 12: Follow-up and review


Conclusion


This research methodology will help provide insights into the factors driving the growth of the nutraceuticals market, allowing the researcher to identify opportunities and potentials within the market. The methodology outlined in this research report enables the researchers to collect and analyse the necessary data to answer the research question, ‘what are the factors driving the growth of the nutraceuticals market?’.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVE ANALYSIS 16

1.1.1 GLOBAL NUTRACEUTICALS MARKET, BY TYPE 17

1.1.2 GLOBAL NUTRACEUTICALS MARKET, BY SOURCE 18

1.1.3 GLOBAL NUTRACEUTICALS MARKET, BY FORM 19

1.1.4 GLOBAL NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL 20

1.1.5 GLOBAL NUTRACEUTICALS MARKET, BY REGION 21

1.2 KEY BUYING CRITERIA 22

2 MARKET INTRODUCTION

2.1 DEFINITION 23

2.2 SCOPE OF THE STUDY 23

2.3 MARKET STRUCTURE 23

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 24

3.2 PRIMARY RESEARCH 25

3.3 SECONDARY RESEARCH 26

3.4 MARKET SIZE ESTIMATION 27

3.5 FORECAST MODEL 28

3.6 LIST OF ASSUMPTIONS 28

4 MARKET DYNAMICS

4.1 INTRODUCTION 29

4.2 DRIVERS 30

4.2.1 INCREASING PREVALENCE OF OBESITY 30

4.2.2 FOCUS ON PREVENTIVE HEALTHCARE 30

4.2.3 GROWING AGING POPULATION 31

4.2.4 DRIVERS IMPACT ANALYSIS 31

4.3 RESTRAINTS 31

4.3.1 STRINGENT GOVERNMENT REGULATIONS 31

4.3.2 RESTRAINTS IMPACT ANALYSIS 32

4.4 OPPORTUNITIES 32

4.4.1 EXPANSION OF THE ORGANIZED RETAIL SECTOR IN EMERGING ECONOMIES 32

4.4.2 RISING CONSUMER INCLINATION TOWARD PERSONALIZED NUTRITION 32

4.5 CHALLENGES 33

4.5.1 LIMITED AWARENESS IN UNDERDEVELOPED ECONOMIES 33

4.5.2 NEED FOR HIGH CAPITAL INVESTMENTS 33

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS 34

5.1.1 RAW MATERIAL PROCUREMENT 35

5.1.2 PROCESSING 35

5.1.3 PACKAGING 35

5.2 SUPPLY CHAIN ANALYSIS 35

5.3 PORTER’S FIVE FORCES MODEL 36

5.3.1 THREAT OF NEW ENTRANTS 37

5.3.2 BARGAINING POWER OF SUPPLIERS 37

5.3.3 BARGAINING POWER OF BUYERS 37

5.3.4 THREAT OF SUBSTITUTES 37

5.3.5 INTENSITY OF RIVALRY 37

6 NUTRACEUTICALS MARKET, BY TYPE

6.1 OVERVIEW 38

6.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY TYPE, 2024-2030 39

6.2 VITAMINS & MINERALS 39

6.2.1 VITAMINS & MINERALS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 39

6.3 PROBIOTICS 40

6.3.1 PROBIOTICS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 40

6.4 PROTEINS & PEPTIDES 40

6.4.1 PROTEINS & PEPTIDES: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 40

6.5 OMEGA FATTY ACIDS 41

6.5.1 OMEGA FATTY ACIDS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 41

6.6 OTHERS 42

6.6.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 42

7 NUTRACEUTICALS MARKET, BY SOURCE

7.1 OVERVIEW 43

7.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY SOURCE, 2024-2030 44

7.2 PLANT 44

7.2.1 PLANT: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 44

7.3 ANIMAL 45

7.3.1 ANIMAL: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 45

7.4 MICROBIAL 46

7.4.1 MICROBIAL: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 46

8 NUTRACEUTICALS MARKET, BY FORM

8.1 OVERVIEW 47

8.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY FORM, 2024-2030 48

8.2 CAPSULES, TABLETS, & SOFTGELS 48

8.2.1 CAPSULES, TABLETS, & SOFTGELS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 48

8.3 POWDER 49

8.3.1 POWDER: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 49

8.4 LIQUID & GUMMIES 50

8.4.1 LIQUID & GUMMIES: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 50

9 NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW 51

9.1.1 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2024-2030 52

9.2 STORE-BASED 52

9.2.1 STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 52

9.3 NON-STORE-BASED 53

9.3.1 NON-STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 53

10 GLOBAL NUTRACEUTICALS MARKET, BY REGION

10.1 OVERVIEW 54

10.2 NORTH AMERICA 56

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.2.1 US 58

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.2.2 CANADA 60

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.2.3 MEXICO 62

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3 EUROPE 64

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.1 GERMANY 66

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.2 UK 68

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.3 FRANCE 70

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.4 SPAIN 71

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.5 ITALY 73

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.3.6 REST OF EUROPE 75

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4 ASIA-PACIFIC 77

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.1 CHINA 79

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.2 INDIA 81

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.3 JAPAN 83

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.4 AUSTRALIA & NEW ZEALAND 84

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.4.5 REST OF ASIA-PACIFIC 86

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5 REST OF THE WORLD 89

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5.1 SOUTH AMERICA 91

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5.2 MIDDLE EAST 93

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

10.5.3 AFRICA 95

NUTRACEUTICALS MARKET, BY TYPE

NUTRACEUTICALS MARKET, BY SOURCE

NUTRACEUTICALS MARKET, BY FORM

NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION 97

11.1.1 MARKET STRATEGY ANALYSIS 97

11.2 COMPETITIVE BENCHMARKING 98

11.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 99

11.3.1 MERGERS & ACQUISITIONS 99

11.3.2 EXPANSIONS 99

11.3.3 JOINT VENTURES 100

11.3.4 PARTNERSHIPS & AGREEMENTS 100

11.3.5 APPROVAL 100

12 COMPANY PROFILES

12.1 PERRIGO COMPANY PLC 101

12.1.1 COMPANY OVERVIEW 101

12.1.2 FINANCIAL OVERVIEW 101

12.1.3 PRODUCTS OFFERED 102

12.1.4 KEY DEVELOPMENTS 102

12.1.5 SWOT ANALYSIS 102

12.1.6 KEY STRATEGIES 102

12.2 GLANBIA PLC 103

12.2.1 COMPANY OVERVIEW 103

12.2.2 FINANCIAL OVERVIEW 103

12.2.3 PRODUCTS OFFERED 104

12.2.4 KEY DEVELOPMENTS 104

12.2.5 SWOT ANALYSIS 105

12.2.6 KEY STRATEGIES 105

12.3 DANONE SA 106

12.3.1 COMPANY OVERVIEW 106

12.3.2 FINANCIAL OVERVIEW 106

12.3.3 PRODUCTS OFFERED 107

12.3.4 KEY DEVELOPMENTS 107

12.3.5 SWOT ANALYSIS 107

12.3.6 KEY STRATEGIES 108

12.4 GLAXOSMITHKLINE PLC 109

12.4.1 COMPANY OVERVIEW 109

12.4.2 FINANCIAL OVERVIEW 109

12.4.3 PRODUCTS OFFERED 110

12.4.4 KEY DEVELOPMENTS 110

12.4.5 SWOT ANALYSIS 111

12.4.6 KEY STRATEGIES 111

12.5 ABBOTT LABORATORIES 112

12.5.1 COMPANY OVERVIEW 112

12.5.2 FINANCIAL OVERVIEW 112

12.5.3 PRODUCTS OFFERED 113

12.5.4 KEY DEVELOPMENTS 114

12.5.5 SWOT ANALYSIS 114

12.5.6 KEY STRATEGIES 115

12.6 DAFLORN LTD 116

12.6.1 COMPANY OVERVIEW 116

12.6.2 FINANCIAL OVERVIEW 116

12.6.3 PRODUCTS OFFERED 116

12.6.4 KEY DEVELOPMENTS 117

12.6.5 KEY STRATEGIES 117

12.7 BACTOLAC PHARMACEUTICAL INC 118

12.7.1 COMPANY OVERVIEW 118

12.7.2 FINANCIAL OVERVIEW 118

12.7.3 PRODUCTS OFFERED 118

12.7.4 KEY DEVELOPMENTS 118

12.7.5 KEY STRATEGIES 119

12.8 YAKULT HONSHA CO., LTD 120

12.8.1 COMPANY OVERVIEW 120

12.8.2 FINANCIAL OVERVIEW 120

12.8.3 PRODUCTS OFFERED 121

12.8.4 KEY DEVELOPMENTS 121

12.8.5 KEY STRATEGIES 122

12.9 MEIJI HOLDINGS CO., LTD 123

12.9.1 COMPANY OVERVIEW 123

12.9.2 FINANCIAL OVERVIEW 123

12.9.3 PRODUCTS OFFERED 124

12.9.4 KEY DEVELOPMENTS 124

12.9.5 KEY STRATEGIES 124

12.10 E.I.D. - PARRY (INDIA) LIMITED 125

12.10.1 COMPANY OVERVIEW 125

12.10.2 FINANCIAL OVERVIEW 125

12.10.3 PRODUCTS OFFERED 126

12.10.4 KEY DEVELOPMENTS 126

12.10.5 KEY STRATEGIES 126

13 REFERENCES

14 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 28

TABLE 2 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY TYPE, 2024-2030 (USD MILLION) 39

TABLE 3 VITAMINS & MINERALS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 39

TABLE 4 PROBIOTICS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 40

TABLE 5 PROTEINS & PEPTIDES: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 40

TABLE 6 OMEGA FATTY ACIDS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 41

TABLE 7 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 42

TABLE 8 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY SOURCE, 2024-2030 (USD MILLION) 44

TABLE 9 PLANT: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 44

TABLE 10 ANIMAL: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 45

TABLE 11 MICROBIAL: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 46

TABLE 12 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY FORM, 2024-2030 (USD MILLION) 48

TABLE 13 CAPSULES, TABLETS, & SOFTGELS: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 48

TABLE 14 POWDER: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 49

TABLE 15 LIQUID & GUMMIES: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 50

TABLE 16 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 52

TABLE 17 STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 52

TABLE 18 NON-STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 53

TABLE 19 GLOBAL NUTRACEUTICALS MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 55

TABLE 20 NORTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2024-2030 (USD MILLION) 56

TABLE 21 NORTH AMERICA: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 57

TABLE 22 NORTH AMERICA: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 57

TABLE 23 NORTH AMERICA: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 57

TABLE 24 NORTH AMERICA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 58

TABLE 25 US: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 58

TABLE 26 US: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 59

TABLE 27 US: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 59

TABLE 28 US: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 59

TABLE 29 CANADA: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 60

TABLE 30 CANADA: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 60

TABLE 31 CANADA: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 61

TABLE 32 CANADA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 61

TABLE 33 MEXICO: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 62

TABLE 34 MEXICO: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 62

TABLE 35 MEXICO: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 62

TABLE 36 MEXICO: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 63

TABLE 37 EUROPE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2024-2030 (USD MILLION) 64

TABLE 38 EUROPE: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 65

TABLE 39 EUROPE: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 65

TABLE 40 EUROPE: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 65

TABLE 41 EUROPE: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 66

TABLE 42 GERMANY: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 66

TABLE 43 GERMANY: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 67

TABLE 44 GERMANY: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 67

TABLE 45 GERMANY: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 67

TABLE 46 UK: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 68

TABLE 47 UK: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 68

TABLE 48 UK: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 69

TABLE 49 UK: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 69

TABLE 50 FRANCE: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 70

TABLE 51 FRANCE: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 70

TABLE 52 FRANCE: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 70

TABLE 53 FRANCE: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 71

TABLE 54 SPAIN: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 71

TABLE 55 SPAIN: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 72

TABLE 56 SPAIN: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 72

TABLE 57 SPAIN: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 72

TABLE 58 ITALY: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 73

TABLE 59 ITALY: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 73

TABLE 60 ITALY: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 74

TABLE 61 ITALY: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 74

TABLE 62 REST OF EUROPE: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 75

TABLE 63 REST OF EUROPE: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 75

TABLE 64 REST OF EUROPE: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 76

TABLE 65 REST OF EUROPE: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 76

TABLE 66 ASIA-PACIFIC: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2024-2030 (USD MILLION) 77

TABLE 67 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 78

TABLE 68 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 78

TABLE 69 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 78

TABLE 70 ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 79

TABLE 71 CHINA: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 79

TABLE 72 CHINA: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 80

TABLE 73 CHINA: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 80

TABLE 74 CHINA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 80

TABLE 75 INDIA: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 81

TABLE 76 INDIA: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 81

TABLE 77 INDIA: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 82

TABLE 78 INDIA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 82

TABLE 79 JAPAN: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 83

TABLE 80 JAPAN: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 83

TABLE 81 JAPAN: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 83

TABLE 82 JAPAN: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 84

TABLE 83 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 84

TABLE 84 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 85

TABLE 85 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 85

TABLE 86 AUSTRALIA & NEW ZEALAND: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 86

TABLE 87 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 86

TABLE 88 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 87

TABLE 89 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 87

TABLE 90 REST OF ASIA-PACIFIC: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 88

TABLE 91 REST OF THE WORLD: MARKET ESTIMATES & FORECAST, BY REGION, 2024-2030 (USD MILLION) 89

TABLE 92 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 90

TABLE 93 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 90

TABLE 94 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 90

TABLE 95 REST OF THE WORLD: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 91

TABLE 96 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 91

TABLE 97 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 92

TABLE 98 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 92

TABLE 99 SOUTH AMERICA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 92

TABLE 100 MIDDLE EAST: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 93

TABLE 101 MIDDLE EAST: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 93

TABLE 102 MIDDLE EAST: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 94

TABLE 103 MIDDLE EAST: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 94

TABLE 104 AFRICA: NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 95

TABLE 105 AFRICA: NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 95

TABLE 106 AFRICA: NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 95

TABLE 107 AFRICA: NUTRACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 96

TABLE 108 GLOBAL NUTRACEUTICALS MARKET: MERGERS & ACQUISITIONS 99

TABLE 109 GLOBAL NUTRACEUTICALS MARKET: EXPANSIONS 99

TABLE 110 GLOBAL NUTRACEUTICALS MARKET: JOINT VENTURES 100

TABLE 111 GLOBAL NUTRACEUTICALS MARKET: PARTNERSHIPS & AGREEMENTS 100

TABLE 112 GLOBAL NUTRACEUTICALS MARKET: APPROVAL 100

TABLE 113 PERRIGO COMPANY PLC: PRODUCTS OFFERED 102

TABLE 114 GLANBIA PLC: PRODUCTS OFFERED 104

TABLE 115 GLANBIA PLC: KEY DEVELOPMENTS 104

TABLE 116 DANONE SA: PRODUCTS OFFERED 107

TABLE 117 GLAXOSMITHKLINE PLC: PRODUCTS OFFERED 110

TABLE 118 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS 110

TABLE 119 ABBOTT LABORATORIES: PRODUCTS OFFERED 113

TABLE 120 DAFLORN LTD: PRODUCTS OFFERED 116

TABLE 121 BACTOLAC PHARMACEUTICAL, INC: PRODUCTS OFFERED 118

TABLE 122 YAKULT HONSHA CO., LTD: PRODUCTS OFFERED 121

TABLE 123 YAKULT HONSHA CO., LTD: KEY DEVELOPMENTS 121

TABLE 124 MEIJI HOLDINGS CO., LTD: PRODUCTS OFFERED 124

TABLE 125 MEIJI HOLDINGS CO., LTD: KEY DEVELOPMENTS 124

TABLE 126 E.I.D. - PARRY (INDIA) LIMITED: PRODUCTS OFFERED 126

TABLE 127 E.I.D. - PARRY (INDIA) LIMITED: KEY DEVELOPMENTS 126

15 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 15

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL NUTRACEUTICALS MARKET 16

FIGURE 3 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY TYPE 17

FIGURE 4 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY SOURCE 18

FIGURE 5 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY FORM 19

FIGURE 6 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY DISTRIBUTION CHANNEL 20

FIGURE 7 GLOBAL NUTRACEUTICALS MARKET ANALYSIS, BY REGION, 2020 21

FIGURE 8 KEY BUYING CRITERIA FOR NUTRACEUTICALS 22

FIGURE 9 GLOBAL NUTRACEUTICALS MARKET: STRUCTURE 23

FIGURE 10 RESEARCH PROCESS 24

FIGURE 11 TOP-DOWN & BOTTOM-UP APPROACHES 27

FIGURE 12 MARKET DYNAMICS OVERVIEW 29

FIGURE 13 DEATHS ATTRIBUTED TO OBESITY, 2020 30

FIGURE 14 DRIVERS IMPACT ANALYSIS: GLOBAL NUTRACEUTICALS MARKET 31

FIGURE 15 RESTRAINTS IMPACT ANALYSIS: GLOBAL NUTRACEUTICALS MARKET 32

FIGURE 16 GLOBAL NUTRACEUTICALS MARKET: VALUE CHAIN 34

FIGURE 17 GLOBAL NUTRACEUTICALS MARKET: SUPPLY CHAIN 35

FIGURE 19 GLOBAL NUTRACEUTICALS MARKET, BY TYPE, 2020 (% SHARE) 38

FIGURE 20 GLOBAL NUTRACEUTICALS MARKET, BY TYPE, 2024-2030 (USD MILLION) 38

FIGURE 21 GLOBAL NUTRACEUTICALS MARKET, BY SOURCE, 2020 (% SHARE) 43

FIGURE 22 GLOBAL NUTRACEUTICALS MARKET, BY SOURCE, 2024-2030 (USD MILLION) 43

FIGURE 23 GLOBAL NUTRACEUTICALS MARKET, BY FORM, 2020 (% SHARE) 47

FIGURE 24 GLOBAL NUTRACEUTICALS MARKET, BY FORM, 2024-2030 (USD MILLION) 47

FIGURE 25 GLOBAL NUTRACEUTICALS MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (% SHARE) 51

FIGURE 26 GLOBAL NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION) 51

FIGURE 27 GLOBAL NUTRACEUTICALS MARKET, BY REGION, 2024-2030 (USD MILLION) 54

FIGURE 28 GLOBAL NUTRACEUTICALS MARKET, BY REGION, 2020 (% SHARE) 54

FIGURE 29 NORTH AMERICA: NUTRACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 56

FIGURE 30 EUROPE: NUTRACEUTICALS MARKET SHARE, BY COUNTRY, 2018 (% SHARE) 64

FIGURE 31 ASIA-PACIFIC: NUTRACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 77

FIGURE 32 REST OF THE WORLD: NUTRACEUTICALS MARKET SHARE, BY REGION, 2020 (% SHARE) 89

FIGURE 33 GLOBAL NUTRACEUTICALS MARKET: COMPETITIVE BENCHMARKING 98

FIGURE 34 PERRIGO COMPANY PLC: FINANCIAL OVERVIEW SNAPSHOT 101

FIGURE 35 PERRIGO COMPANY PLC: SWOT ANALYSIS 102

FIGURE 36 GLANBIA PLC: FINANCIAL OVERVIEW SNAPSHOT 103

FIGURE 37 GLANBIA PLC: SWOT ANALYSIS 105

FIGURE 38 DANONE SA: FINANCIAL OVERVIEW SNAPSHOT 106

FIGURE 39 DANONE SA: SWOT ANALYSIS 107

FIGURE 40 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT 109

FIGURE 41 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 111

FIGURE 42 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 112

FIGURE 43 ABBOTT LABORATORIES: SWOT ANALYSIS 114

FIGURE 44 YAKULT HONSHA CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 120

FIGURE 45 MEIJI HOLDINGS CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 46 E.I.D. - PARRY (INDIA) LIMITED: FINANCIAL OVERVIEW SNAPSHOT 125

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Xanthan Gum Market Research Report—Global Forecast till 2030
report-img
Neem Extracts Market Research Report - Global Forecast till 2032
report-img
Folate Market Research Report - Forecast till 2030
report-img
Citric Acid Market Research Report - Global Forecast till 2030
Press Release
Category icon
By 2030, the nutraceuticals market is projected to register a CAGR of 7.90% and reach a market si...
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)